Cite
HARVARD Citation
Grande, E. et al. (n.d.). Effect of prior systemic therapy on clinical outcomes with cabozantinib vs everolimus in advanced renal cell carcinoma: Results from the phase 3 METEOR study. European journal of cancer. pp. S197-S198. [Online].